These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15225366)

  • 1. Nifedipine decreases sVCAM-1 concentrations and oxidative stress in systemic sclerosis but does not affect the concentrations of vascular endothelial growth factor or its soluble receptor 1.
    Allanore Y; Borderie D; Lemaréchal H; Ekindjian OG; Kahan A
    Arthritis Res Ther; 2004; 6(4):R309-14. PubMed ID: 15225366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble adhesion molecules (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in patients with systemic sclerosis: relationship to organ systemic involvement.
    Kuryliszyn-Moskal A; Klimiuk PA; Sierakowski S
    Clin Rheumatol; 2005 Apr; 24(2):111-6. PubMed ID: 15349798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of etanercept on serum levels of soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor in patients with rheumatoid arthritis.
    Klimiuk PA; Sierakowski S; Domyslawska I; Chwiecko J
    Scand J Rheumatol; 2009; 38(6):439-44. PubMed ID: 19922018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of preoperative plasma levels of vascular endothelial growth factor and soluble vascular cell adhesion molecule-1 with lymph node status and biochemical progression after radical prostatectomy.
    Shariat SF; Anwuri VA; Lamb DJ; Shah NV; Wheeler TM; Slawin KM
    J Clin Oncol; 2004 May; 22(9):1655-63. PubMed ID: 15117988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenesis in systemic sclerosis: impaired expression of vascular endothelial growth factor receptor 1 in endothelial progenitor-derived cells under hypoxic conditions.
    Avouac J; Wipff J; Goldman O; Ruiz B; Couraud PO; Chiocchia G; Kahan A; Boileau C; Uzan G; Allanore Y
    Arthritis Rheum; 2008 Nov; 58(11):3550-61. PubMed ID: 18975312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of soluble adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor levels in serum of rheumatoid arthritis patients following multiple intravenous infusions of infliximab.
    Klimiuk PA; Sierakowski S; Domysławska I; Fiedorczyk M; Chwiećko J
    Arch Immunol Ther Exp (Warsz); 2004; 52(1):36-42. PubMed ID: 15053231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated vascular endothelial growth factor in systemic sclerosis.
    Choi JJ; Min DJ; Cho ML; Min SY; Kim SJ; Lee SS; Park KS; Seo YI; Kim WU; Park SH; Cho CS
    J Rheumatol; 2003 Jul; 30(7):1529-33. PubMed ID: 12858453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between increased nitric oxide production and markers of endothelial activation in systemic sclerosis: findings with the soluble adhesion molecules E-selectin, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1.
    Andersen GN; Caidahl K; Kazzam E; Petersson AS; Waldenström A; Mincheva-Nilsson L; Rantapää-Dahlqvist S
    Arthritis Rheum; 2000 May; 43(5):1085-93. PubMed ID: 10817563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and sustained effects of dihydropyridine-type calcium channel antagonists on oxidative stress in systemic sclerosis.
    Allanore Y; Borderie D; Lemaréchal H; Ekindjian OG; Kahan A
    Am J Med; 2004 May; 116(9):595-600. PubMed ID: 15093755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the association of serum levels of hyaluronic acid, sICAM-1, sVCAM-1, and VEGF-A with mortality and prognosis in patients with Crimean-Congo hemorrhagic fever.
    Ozturk B; Kuscu F; Tutuncu E; Sencan I; Gurbuz Y; Tuzun H
    J Clin Virol; 2010 Feb; 47(2):115-9. PubMed ID: 20005156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of circulating vascular endothelial growth factor and soluble adhesion molecules as reliable predictors of native arteriovenous fistula thrombosis in chronic hemodialysis patients.
    Zohny SF; Abd el-Fattah M
    Clin Biochem; 2008 Oct; 41(14-15):1175-80. PubMed ID: 18692491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum tumor necrosis factor alpha (TNF-alpha) concentration correlates with soluble adhesion molecules and vascular endothelial growth factor (VEGF) in rheumatoid arthritis].
    Klimiuk PA; Sierakowski S; Fiedorczyk M; Chwiećko J
    Przegl Lek; 2004; 61(2):86-9. PubMed ID: 15230147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of aminaftone 75 mg TID on soluble adhesion molecules: a 12-week, randomized, open-label pilot study in patients with systemic sclerosis.
    Scorza R; Santaniello A; Salazar G; Lenna S; Della Bella S; Antonioli R; Toussoun K; Beretta L
    Clin Ther; 2008 May; 30(5):924-9. PubMed ID: 18555939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin].
    Dziankowska-Bartkowiak B; Zebrowska A; Wagrowska-Danielewicz M; Kobos J; Waszczykowska E
    Przegl Lek; 2009; 66(12):1040-5. PubMed ID: 20514902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostacyclin analogue iloprost influences endothelial cell-associated soluble adhesion molecules and growth factors in patients with systemic sclerosis: a time course study of serum concentrations.
    Rehberger P; Beckheinrich-Mrowka P; Haustein UF; Sticherling M
    Acta Derm Venereol; 2009; 89(3):245-9. PubMed ID: 19479119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
    Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
    Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenic and inflammatory biomarkers for screening and follow-up in patients with pulmonary arterial hypertension.
    Kylhammar D; Hesselstrand R; Nielsen S; Scheele C; Rådegran G
    Scand J Rheumatol; 2018 Jul; 47(4):319-324. PubMed ID: 29528272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of soluble vascular endothelial growth factor receptor-2 in patients with systemic sclerosis.
    Jinnin M; Makino T; Kajihara I; Honda N; Makino K; Ogata A; Ihn H
    Br J Dermatol; 2010 Apr; 162(4):751-8. PubMed ID: 19886888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating VEGF and its soluble receptors sVEGFR-1 and sVEGFR-2 in patients with acute leukemia.
    Wierzbowska A; Robak T; Wrzesień-Kuś A; Krawczyńska A; Lech-Marańda E; Urbańska-Ryś H
    Eur Cytokine Netw; 2003; 14(3):149-53. PubMed ID: 14656688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nifedipine protects against overproduction of superoxide anion by monocytes from patients with systemic sclerosis.
    Allanore Y; Borderie D; Périanin A; Lemaréchal H; Ekindjian OG; Kahan A
    Arthritis Res Ther; 2005; 7(1):R93-100. PubMed ID: 15642147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.